ProfileGDS5822 / ILMN_2496281
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 14% 15% 39% 27% 7% 1% 35% 57% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 111.214
GSM1276600PDAC Late Ablation Control 213.315
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 115.939
GSM1276603PDAC Late Ablation 214.327
GSM1276604PDAC Late Ablation 36.87
GSM1303940PDAC Late Ablation_anti-CTLA4 12.41
GSM1303941PDAC Late Ablation_anti-CTLA4 216.635
GSM1303942PDAC Late Ablation_anti-CTLA4 332.657